Sarepta (SRPT) PT Raised to $76 at Oppenheimer Amid Eteplirsen Approval

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. NVDA
2. PCG
3. AMZN
4. AAPL
5. AVGO
6. EC
7. ALNY
8. CNS
9. STLA
10. PTGX

Go back to Sarepta (SRPT) PT Raised to $76 at Oppenheimer Amid Eteplirsen Approval
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 21.03 --0 (-0%)
Previous Close $21.03    52 Week High $63.73 
Open $21.03    52 Week Low $8.00 
Day High $21.03    P/E N/A 
Day Low $21.03    EPS $-5.69 
Volume 118